653 related articles for article (PubMed ID: 17898800)
21. Three-year follow-up of androgen treatment in hypogonadal men: preliminary report with testosterone gel.
Swerdloff RS; Wang C
Aging Male; 2003 Sep; 6(3):207-11. PubMed ID: 14628501
[TBL] [Abstract][Full Text] [Related]
22. 12-month observation of testosterone replacement effectiveness in a general population of men.
Miner MM; Bhattacharya RK; Blick G; Kushner H; Khera M
Postgrad Med; 2013 Mar; 125(2):8-18. PubMed ID: 23816767
[TBL] [Abstract][Full Text] [Related]
23. Clomiphene citrate and testosterone gel replacement therapy for male hypogonadism: efficacy and treatment cost.
Taylor F; Levine L
J Sex Med; 2010 Jan; 7(1 Pt 1):269-76. PubMed ID: 19694928
[TBL] [Abstract][Full Text] [Related]
24. Testosterone replacement therapy outcomes among opioid users: the Testim Registry in the United States (TRiUS).
Blick G; Khera M; Bhattacharya RK; Nguyen D; Kushner H; Miner MM
Pain Med; 2012 May; 13(5):688-98. PubMed ID: 22536837
[TBL] [Abstract][Full Text] [Related]
25. Combined use of androgen and sildenafil for hypogonadal patients unresponsive to sildenafil alone.
Hwang TI; Chen HE; Tsai TF; Lin YC
Int J Impot Res; 2006; 18(4):400-4. PubMed ID: 16395321
[TBL] [Abstract][Full Text] [Related]
26. A novel testosterone 2% gel for the treatment of hypogonadal males.
Dobs AS; McGettigan J; Norwood P; Howell J; Waldie E; Chen Y
J Androl; 2012; 33(4):601-7. PubMed ID: 21979302
[TBL] [Abstract][Full Text] [Related]
27. Review of Testim gel.
McNicholas T; Ong T
Expert Opin Pharmacother; 2006 Mar; 7(4):477-84. PubMed ID: 16503819
[TBL] [Abstract][Full Text] [Related]
28. Compounded percutaneous testosterone gel: use and effects in hypogonadal men.
Cutter CB
J Am Board Fam Pract; 2001; 14(1):22-32. PubMed ID: 11206690
[TBL] [Abstract][Full Text] [Related]
29. Sildenafil improves sleep-related erections in hypogonadal men: evidence from a randomized, placebo-controlled, crossover study of a synergic role for both testosterone and sildenafil on penile erections.
Rochira V; Balestrieri A; Madeo B; Granata AR; Carani C
J Androl; 2006; 27(2):165-75. PubMed ID: 16278367
[TBL] [Abstract][Full Text] [Related]
30. Subjective sexual response to testosterone replacement therapy based on initial serum levels of total testosterone.
Reyes-Vallejo L; Lazarou S; Morgentaler A
J Sex Med; 2007 Nov; 4(6):1757-62. PubMed ID: 17087806
[TBL] [Abstract][Full Text] [Related]
31. Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report.
Morrison BF; Reid M; Madden W; Burnett AL
Andrology; 2013 Jul; 1(4):576-82. PubMed ID: 23606509
[TBL] [Abstract][Full Text] [Related]
32. Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS).
Bhattacharya RK; Khera M; Blick G; Kushner H; Miner MM
Clin Interv Aging; 2012; 7():321-30. PubMed ID: 22956867
[TBL] [Abstract][Full Text] [Related]
33. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.
Wang C; Cunningham G; Dobs A; Iranmanesh A; Matsumoto AM; Snyder PJ; Weber T; Berman N; Hull L; Swerdloff RS
J Clin Endocrinol Metab; 2004 May; 89(5):2085-98. PubMed ID: 15126525
[TBL] [Abstract][Full Text] [Related]
34. Effect of aromatizable and unaromatizable androgen replacement in hypogonadal men on GH responsiveness.
Gleeson HK; Shalet SM
Clin Endocrinol (Oxf); 2009 Jan; 70(1):109-15. PubMed ID: 18549466
[TBL] [Abstract][Full Text] [Related]
35. A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function.
McNicholas TA; Dean JD; Mulder H; Carnegie C; Jones NA
BJU Int; 2003 Jan; 91(1):69-74. PubMed ID: 12614254
[TBL] [Abstract][Full Text] [Related]
36. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices.
Miner M; Canty DJ; Shabsigh R
Postgrad Med; 2008 Sep; 120(3):130-53. PubMed ID: 18824832
[TBL] [Abstract][Full Text] [Related]
37. Adjunctive use of AndroGel (testosterone gel) with sildenafil to treat erectile dysfunction in men with acquired androgen deficiency syndrome after failure using sildenafil alone.
Rosenthal BD; May NR; Metro MJ; Harkaway RC; Ginsberg PC
Urology; 2006 Mar; 67(3):571-4. PubMed ID: 16527581
[TBL] [Abstract][Full Text] [Related]
38. The long-term efficacy and safety of a testosterone mucoadhesive buccal tablet in testosterone-deficient men.
Dinsmore WW; Wyllie MG
BJU Int; 2012 Jul; 110(2):162-9. PubMed ID: 22288877
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety study of 1.62% testosterone gel for the treatment of hypogonadal men.
Kaufman JM; Miller MG; Garwin JL; Fitzpatrick S; McWhirter C; Brennan JJ
J Sex Med; 2011 Jul; 8(7):2079-89. PubMed ID: 21492400
[TBL] [Abstract][Full Text] [Related]
40. Testosterone supplementation does not worsen lower urinary tract symptoms.
Pearl JA; Berhanu D; François N; Masson P; Zargaroff S; Cashy J; McVary KT
J Urol; 2013 Nov; 190(5):1828-33. PubMed ID: 23764078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]